Document ID: chunk:federal_register_of_legislation:F2018C00196:clause:1_1:p3
Version: federal_register_of_legislation:F2018C00196
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 3/3)
Character Range: 17709–19433

= Federal Register of Legislation             rep = repealed
gaz = gazette                                   rs = repealed and substituted
LA = Legislation Act 2003                       s = section(s)/subsection(s)
LIA = Legislative Instruments Act 2003          Sch = Schedule(s)
(md) = misdescribed amendment can be given      Sdiv = Subdivision(s)
    effect                                      SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
    cannot be given effect                      Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
                                                    commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                                   Registration    Commencement     Application, saving and transitional provisions
Statement of Principles concerning malignant neoplasm of the ovary (Reasonable Hypothesis) (No. 9 of 2018)             2 January 2018  29 January 2018

                                                                                                                       F2018L00010
Amendment Statement of Principles concerning malignant neoplasm of the ovary (Reasonable Hypothesis) (No. 35 of 2018)  5 March 2018    2 April 2018

                                                                                                                       F2018L00185

Endnote 4—Amendment history

Provision affected      How affected
Subsection 10(2)..……..  rs Instrument No. 35 of 2018